Cellpoint

Cellpoint company information, Employees & Contact Information

Explore related pages

Related company profiles:

CellPoint enables clinicians to treat hematological malignancies by retargeting patient immune cells at the point-of-care. In 2022, CellPoint was acquired by Galapagos, a fully integrated biotechnology company. Since then, they have been united around a single purpose: to transform patient outcomes through life-changing science and innovation for more years of life and quality of life. As a result, we will be sharing all company updates, news, and insights on the Galapagos’ page as of now. Please follow Galapagos to stay updated on our latest developments and join our vibrant community. This page will stay online for cv referencing and historic purposes but will not be used to communicate updates. For details on the acquisition, please read our press release from 22 June 2022: https://www.glpg.com/press-release/3637/galapagos-to-acquire-cellpoint-and-aboundbio-to-accelerate-access-to-next-generation-cell-therapies

Company Details

Employees
57
Address
Limes, 7,netherlands
Phone
+31 712077810
Email
in****@****int.bio
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Oegstgeest, South Holland
Looking for a particular Cellpoint employee's phone or email?

Cellpoint Questions

News

Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech - BioSpace

Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech BioSpace

Galapagos sources CEO for oncology spin-off as Stoffels plans exit - The Pharma Letter

Galapagos sources CEO for oncology spin-off as Stoffels plans exit The Pharma Letter

Galapagos to acquire CellPoint and AboundBio to advance cell therapies - Labiotech.eu

Galapagos to acquire CellPoint and AboundBio to advance cell therapies Labiotech.eu

Galapagos to buy CellPoint, AboundBio to boost access to cell therapies - Pharmaceutical Technology

Galapagos to buy CellPoint, AboundBio to boost access to cell therapies Pharmaceutical Technology

Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies - GlobeNewswire

Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies GlobeNewswire

Galapagos makes ‘surprising’ cell therapy pivot via CellPoint and AboundBio buy - BioProcess International

Galapagos makes ‘surprising’ cell therapy pivot via CellPoint and AboundBio buy BioProcess International

AZ entered deal with Harbour Biomed for Claudin18.2 bispecific for up to $350 million - PPF Group

AZ entered deal with Harbour Biomed for Claudin18.2 bispecific for up to $350 million PPF Group

Top Cellpoint Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant